With an ongoing need to conduct an expanding number of global clinical trials, Galderma said that its data management team conducted a six-month evaluation of three vendors before selecting Medidata Solutions.

Galderma Global Data Management head Francis Gon said that Medidata’s training and eLearning tools made it easy for them to take the solution in-house and begin to independently build and execute studies in any phase and in multiple languages.

Medidata Solutions president Glen de Vries said that Galderma’s approach to the implementation of Medidata Rave will maximise its ROI and clinical development efficiencies.